Activated T cells and cytokine-induced CD3+CD56+ killer cells

被引：0
|
作者：
G. D. Schmidt-Wolf
R. S. Negrin
I. G. H. Schmidt-Wolf
机构：
[1] Department of Medicine,
[2] Division of Hematology/Oncology,undefined
[3] Virchow Clinic of Humboldt University,undefined
[4] Augustenburger Platz 1,undefined
[5] D-13353 Berlin,undefined
[6] Germany,undefined
[7] Bone Marrow Transplantation Program,undefined
[8] Stanford University Medical Center,undefined
[9] Stanford,undefined
[10] CA,undefined
[11] USA,undefined
来源：
Annals of Hematology | 1997年 / 74卷
关键词：
Key words T cells; Cytokine-induced killer cells; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
 Over the past two decades, attempts have been made to develop immunotherapy for patients with cancer. A significant obstacle to the development of successful adoptive immunotherapy has been the availability of appropriate cytotoxic cells. Immunologic effector cells such as lymphokine-activated killer (LAK) cells, activated T cells such as tumor-infiltrating lymphocytes (TILs), and cytokine-induced killer (CIK) cells may be suitable to remove residual tumor cells.
引用
收藏
页码：51 / 56
页数：5
相关论文
共 50 条
  • [21] Expression of inhibitory receptors in, natural killer (CD3-CD56+) cells and CD3+CD56+ cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma
    Yuen, MF
    Norris, S
    [J]. CLINICAL IMMUNOLOGY, 2001, 101 (03) : 264 - 269
  • [22] CD4+CD25+ Regulatory T Cells Decreased the Antitumor Activity of Cytokine-Induced Killer (CIK) Cells of Lung Cancer Patients
    Hui Li
    Jin-Pu Yu
    Shui Cao
    Feng Wei
    Peng Zhang
    Xiu-Mei An
    Zong-Tang Huang
    Xiu-Bao Ren
    [J]. Journal of Clinical Immunology, 2007, 27 : 317 - 326
  • [23] CD4+CD25+ regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients
    Li, Hui
    Yu, Jin-Pu
    Cao, Shui
    Wei, Feng
    Zhang, Peng
    An, Xiu-Mei
    Huang, Zong-Tang
    Ren, Xiu-Bao
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2007, 27 (03) : 317 - 326
  • [24] Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells
    Han, Lu
    Shang, Yi-Man
    Song, Yong-Ping
    Gao, Quan-Li
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [25] 2 PATHWAYS OF EXOCYTOSIS OF CYTOPLASMIC GRANULE CONTENTS AND TARGET-CELL KILLING BY CYTOKINE-INDUCED CD3(+)CD56(+) KILLER-CELLS
    MEHTA, BA
    SCHMIDTWOLF, GH
    WEISSMAN, IL
    NEGRIN, RS
    [J]. BLOOD, 1995, 86 (09) : 3493 - 3499
  • [26] Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis
    Michael R. Verneris
    Martin Kornacker
    Volker Mailänder
    Robert S. Negrin
    [J]. Cancer Immunology, Immunotherapy, 2000, 49 : 335 - 345
  • [27] Sunitinib Indirectly Enhanced Anti-Tumor Cytotoxicity of Cytokine-Induced Killer Cells and CD3+ CD56+ Subset through the Co-Culturing Dendritic Cells
    Wongkajornsilp, Adisak
    Wamanuttajinda, Valla
    Kasetsinsombat, Kanda
    Duangsa-ard, Sunisa
    Sa-ngiamsuntorn, Khanit
    Hongeng, Suradej
    Maneechotesuwan, Kittipong
    [J]. PLOS ONE, 2013, 8 (11):
  • [28] Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis
    Verneris, MR
    Kornacker, M
    Mailänder, V
    Negrin, RS
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (06) : 335 - 345
  • [29] Flow cytometric visualisation of cytokine production by CD3-CD56+NK cells and CD3+CD56+NK-T cells in whole blood
    Mendes, R
    Bromelow, KV
    Westby, M
    Galea-Lauri, J
    Smith, IE
    O'Brien, MER
    Souberbielle, BE
    [J]. CYTOMETRY, 2000, 39 (01): : 72 - 78
  • [30] Cord blood CD4+/CD25+ T cells down-regulates NKG2D on cytokine-induced killer cells
    Liu, Aihua
    Wang, Qian
    Yang, Xianyong
    Shen, Shaohua
    Xu, Yuzhen
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2019, 24 : 1259 - 1270
12345